All In MedTech

FDA Clearance Tracker · P970004-S040

MEDTRONIC INTERSTIM TINED LEAD MODELS 3889 & 3093

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 23, 2007 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 23, 2007

Approved

Time to decision

284 days

Received Jan 12, 2007. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P970004-S040
Device name
MEDTRONIC INTERSTIM TINED LEAD MODELS 3889 & 3093
Applicant location
Minneapolis, MN
Received
Jan 12, 2007
Decided
Oct 23, 2007
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P970004

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code EZW

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY.

Source documents

Other decisions for Medtronic Neuromodulation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.